Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beta lactam antibiotics are a broad class of bactericidal agents characterized by the presence of a beta-lactam ring in their chemical structure. They inhibit bacterial cell wall biosynthesis by binding to penicillin-binding proteins (PBPs), leading to bacterial lysis and death. Resistance mechanisms include beta-lactamase production and modification of PBPs. The main adverse effect is allergic reaction.
Beta lactams bind irreversibly to active site serine residues on PBPs, inhibiting transpeptidase activity required for peptidoglycan cross-linking. The disruption weakens the cell wall structure, leading to bacteriolysis.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta Lactam Antibiotics (Beta Lactams).